Bill Pagels, Phd work email
- Valid
- Valid
- Valid
Bill Pagels, Phd personal email
Bill Pagels, Phd phone numbers
Specialties: Marketing / market research; Business plans & marketing plans; Strategic planning; Executive leadership; Technology licensing; Technology development & technology commercialization
-
Chief Executive OfficerAperiondxCarlsbad, Ca, Us
-
Member Board Of DirectorsActt Med Apr 2021 - PresentACTT Med is a portable device that works via transdermal pads on the skin or by sitting or lying on a grounding sheet or pad that increase vibrational energy. It is imperceptible and can be used safely while sleeping or being active. ACTT Med is not FDA approved and is used only for experimental purposes. See disclaimer.Two main processes occur at the cellular level during exposure to ACTT Med's alternating current: diseased proliferation is halted, and excessively dividing cells are destroyed. This gives your body's previously overwhelmed immune system a chance to mount a proper defense or recover with supplemental medicinal treatment.The electrical charge has the ability to disrupt proliferating cells, and the cell division process, inhibiting the multiplication of diseased cells. A similar technology has been used for many years with no known safety issues or adverse side effects.The ACTT Med device delivers a high frequency, very low amperage, low wattage, low voltage charge. A similar FDA certified, high frequency, alternating current device has already been approved for use in the treatment of two types of cancers.
-
Chief Executive OfficerReliable-Lfc, Llc May 2020 - PresentReliable-LFC is the sole rapid antigen test winner of the coveted and recent XPRIZE Foundation's RapidCOVID competition with >700 competitors from 38 countries. Although not currently available in the US, Reliable sells its rapid, inexpensive, easy to use tests internationally with the focus of contributing to curtailing the pandemic.Reliable-LFC has won a contract with the U.S. Air Force interested in Reliable's platform technology to diagnose and stratify patients with neurological trauma associated with multiple diseases including TBI (Traumatic Brain Injury), Parkinson's Disease, ALT, Alzheimer's Disease and potentially CTE (Chronic Traumatic Encephalopathy). As a platform diagnostic technology, ultra-high sensitivity analyses are possible for other disease states and Reliable has demonstrated feasibility for detecting COVID, heart attacks, inflammation from cancer, and these neurological disorders.
-
Ceo / Chief Scientific OfficerApollodx Apr 2014 - PresentSalt Lake City, Ut, UsApolloDx develops its mobile IVD platform for real-time detection, tracking and trending of infectious diseases and bio-threat agents. ApolloDx’s Mobile IVD Platform is an easy-to-use, smartdevice-based, inexpensive system that provides and transmits geotagged laboratory-quality results to remote servers in real-time. The bidirectional data transmission, integration and real-time analytics enable high-quality decisions based on objective results, as well as data tracking and trending that can be securely viewed by other parties. -
CeoBiomedical Consultants, Inc. 2005 - PresentConsulting to the State of Utah Centers of Excellence Program to drive technologies from research laboratories to market. Public and private clients in biotechnology (microarrays), medical devices (needle stick injury protection), medical diagnostics (appendicitis testing), HIV diagnostics, and nanotechnology.
-
Co-FounderCibus Biotechnologies Jun 2017 - Apr 2020Salt Lake City, Ut, UsFood safety diagnostics and therapeutics -
Ceo3Pdx, Llc Jul 2012 - Mar 20143PDx developed a broadly applicable platform technology that both to decentralize many tests that are traditionally performed in central laboratories by trained technicians. The market segments for 3PDx's simple test format are laypeople, physician offices, clinics, etc. without the training, time or inclination to routinely conduct rigorous, technical procedures.
-
Co-Founder4M Ventures, Llc Apr 2012 - Jul 20124M assists small- and mid-sized companies prepare for a funding event in order to extract the full value of their technology/expertise. We address the needs of companies in industries as diverse as the life sciences, medical devices, web-based education, IT, consumer goods and energy.
-
Vp / FounderGrow Emerging Companies, Llc 2009 - 2012Depoe Bay, Or, UsGrow offers unmatched expertise in helping innovative firms obtain R&D funding from the federal government. Grow's co-founder, Mark Henry, is the foremost SBIR/STTR grant writing advisor in the country having participated in submitting >2000 grant proposals over the past almost 30 years. Mark's success in obtaining funding for clients is, for Phase I and Phase II respectively, 5-times and 2-times the national average. Grow assists clients in securing government contracts too. Grow's last two government contract clients received notices of allowance for $112MIL in funding. -
U.S. RepresentativeH.M.Pharma Consultancy 2006 - 2007H.M. Pharma Consultancy is a new type of solution provider for the life science industry -- a data-driven knowledge foundry in the service of pharmaceutical and medical business development. With deep scientific expertise, advanced data retrieval modalities, and cutting edge knowledge management, the company specializes in, among other areas, strategic patenting - drilling deep within intellectual patent domains to exploit unclaimed territory for clients' benefit. Scientific areas of particular strength include: ophthalmology (pharmaceuticals and surgical procedures), cardiorespiratory medicine (hypertension and imaging), central/peripheral nervous system (psychiatry and neurology), urology and viral infection.
-
Manager, Laboratory ServicesAbbott Laboratories 2002 - 2005Abbott Park, Illinois, UsDirected biological, chemical and microbiological test development and evaluation of Abbott's/Hospira's medical devices high volume manufacturing operations. -
Vp Business Development & MarketingBiomicro Systems, Inc. 2000 - 2002UsLed commercial development and market introduction of the first-of-kind microarray sample mixing system called "MAUI" establishing a customer base leading to the eventual acquisition by Roche. -
Director Of Business Development; Acting Director Of Qa, Clinical Affairs, Regulatory AffairsLumenal Technologies, Lp 1998 - 1999Directed all business development, marketing, clinical affairs, regulatory affairs, QA, product management and corporate communications.Forty person diagnostics company with leading platform for rapid, pseudohomogeneous diagnostics applicable to cardiovascular events, military warfare agents, environmental/agricultural diagnostics, veterinary diagnostics and life sciences research.Technology received the coveted R&D 100 Award for country's top high tech technology of the year.
-
Product Marketing ManagerBoston Scientific 1996 - 1998Marlborough, Ma, UsManaged $350MIL domestic / $450MIL international product lines including cardiovascular grafts, cardiovascular fabrics and hernia products. -
Director Of DevelopmentJohnson & Johnson (Direct Access Diagnostics) 1993 - 1996New Brunswick, Nj, UsDeveloper of the first-of-kind OTC HIV Test Blood Collection kit, called "Confide". Received PMA approval from FDA in 1996.Multiple patent applications.Initiated development of next generation saliva-based HIV testing devices. -
Technical Marketing ManagerJohnson & Johnson (Direct Access Diagnostics) 1990 - 1993New Brunswick, Nj, UsDeveloped and commercialized multiplicity of IVD systems and assays for infectious disease testing. Market focus: blood bank testing industry. -
Senior Development BiochemistDupont Biomedical Products 1981 - 1990Developed clinical and infectious disease diagnostic tests including the first-of-kind rapid, equipment-free, market-leading test, HIVCHEK(tm). HIVCHEK received distinction as one of the best technologies of the year, the IR100 Award, in 1989.
Bill Pagels, Phd Skills
Bill Pagels, Phd Education Details
-
Wayne State UniversityBiochemistry -
Adelphi UniversityMasters Studies In Chemistry -
Hofstra UniversitySociology
Frequently Asked Questions about Bill Pagels, Phd
What company does Bill Pagels, Phd work for?
Bill Pagels, Phd works for Aperiondx
What is Bill Pagels, Phd's role at the current company?
Bill Pagels, Phd's current role is Chief Executive Officer.
What is Bill Pagels, Phd's email address?
Bill Pagels, Phd's email address is 20****@****cro.com
What is Bill Pagels, Phd's direct phone number?
Bill Pagels, Phd's direct phone number is +180125*****
What schools did Bill Pagels, Phd attend?
Bill Pagels, Phd attended Wayne State University, Adelphi University, Hofstra University.
What are some of Bill Pagels, Phd's interests?
Bill Pagels, Phd has interest in Science And Technology, Health.
What skills is Bill Pagels, Phd known for?
Bill Pagels, Phd has skills like Biotechnology, Medical Devices, Lifesciences, Commercialization, Strategy, Pharmaceutical Industry, Strategic Planning, Fda, Business Development, Technology Transfer, Product Development, Start Ups.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial